CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery

BACKGROUND: There is no consensus regarding the management of ovarian cancer patients, who have shown complete clinical response (CCR) to primary therapy and have rising cancer antigen CA-125 levels but have no symptoms of recurrent disease. The present study aims to determine whether follow-up CA-1...

Full description

Saved in:
Bibliographic Details
Main Authors: Wang, Fang, Ye, Yanfen, Xu, Xia, Zhou, Xuehui, Wang, Jinhua, Chen, Xiaoxiang
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3576242/
https://ncbi.nlm.nih.gov/pubmed/23402322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1757-2215-6-14
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items